SCHEMBL6635634

SCHEMBL6635634

O=C(OCc1ccccc1)N1C2CCC(CNc3ncnc4[nH]cnc34)C1CC2

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 1/20 0.43
AGTR2 P50052 5/20 0.40
GRIN2B Q13224 6/20 0.39
CYP2D6 P10635 3/20 0.38
CYP2C9 P11712 3/20 0.38
CYP3A4 P08684 2/20 0.38
HTR2C P28335 1/20 0.38
SMN1; SMN2 Q16637 3/20 0.37
HDAC1 Q13547 1/20 0.37
CYP2C19 P33261 1/20 0.37
JAK2 O60674 3/20 0.37
JAK1 P23458 3/20 0.37
TYK2 P29597 1/20 0.37
JAK3 P52333 1/20 0.37
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5359791 0.86 GRIN2B (0.44) ADORA1GRIN2BCYP2D6CYP2C9CYP3A4
SCHEMBL5359788 0.86 GRIN2B (0.44) ADORA1GRIN2BCYP2D6CYP2C9CYP3A4
SCHEMBL5351078 0.80 GRIN2B (0.63) GRIN2BCYP2D6CYP2C9CYP3A4
SCHEMBL5353306 0.79 GRIN2B (0.56) GRIN2BCYP2D6CYP2C9CYP3A4SMN1; SMN2
SCHEMBL6637671 0.77 GRIN2B (0.61) AGTR2GRIN2BCYP2D6CYP2C9CYP3A4
SCHEMBL6753016 0.71 POLB (0.48) SMN1; SMN2NPC1RAB9A
SCHEMBL17453692 0.69 AGTR2 (0.54) ADORA1AGTR2HTR2CSMN1; SMN2CYP2C19
SCHEMBL5358459 0.69 GRIN2B (0.60) GRIN2BCYP2D6CYP2C9CYP3A4SMN1; SMN2
SCHEMBL25125018 0.69 HTR2C (0.61) AGTR2HTR2CSMN1; SMN2CYP2C19NPC1
SCHEMBL25215518 0.68 AGTR2 (0.56) AGTR2HTR2CSMN1; SMN2CYP2C19NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1379520-A1 N-SUBSTITUTED NONARYL-HETEROCYCLIC NMDA/NR2B ANTAGONISTS Merck & Co., Inc. (US) 2004-01-14 EP disclosed
WO-2002068409-A1 N-SUBSTITUTED NONARYL-HETEROCYCLIC NMDA/NR2B ANTAGONISTS MERCK & CO., INC. (US) 2002-09-06 WO disclosed